| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIACARE.7.5.491 |
| P953 | full work available at URL | https://diabetesjournals.org/care/article-pdf/7/5/491/496739/7-5-491.pdf |
| P698 | PubMed publication ID | 6094129 |
| P5875 | ResearchGate publication ID | 17092434 |
| P2093 | author name string | Porte D Jr | |
| D. Porte | |||
| J. B. Halter | |||
| M. A. Pfeifer | |||
| W. K. Ward | |||
| J. C. Beard | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | internal medicine | Q11180 |
| pathophysiology | Q1135939 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 491-502 | |
| P577 | publication date | 1984-09-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus | |
| Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes Mellitus | |||
| P478 | volume | 7 |
| Q51636795 | A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence. |
| Q44300202 | Adaptation of ovine fetal pancreatic insulin secretion to chronic hypoglycaemia and euglycaemic correction. |
| Q39753165 | Assays of pancreatic B cell secretory products: utility in investigative and clinical diabetology |
| Q37617131 | Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states |
| Q35578203 | B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia |
| Q36462620 | Cardiomyopathy associated with noninsulin-dependent diabetes |
| Q34544816 | Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent |
| Q51609984 | Comparison of Indices of Islet B-cell Function in Type 2 Diabetes in Relation to Insulin Effectiveness and Clinical Outcome |
| Q35651511 | Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications |
| Q43136282 | Determinants of glucose control in patients with chronic pancreatitis |
| Q90116085 | Development of therapeutic options on type 2 diabetes in years: Glucagon-like peptide-1 receptor agonist's role intreatment; from the past to future |
| Q38682677 | Diabetes mellitus in American Indians: characteristics, origins and preventive health care implications |
| Q70260856 | Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications |
| Q39670219 | Dietary sugars and carbohydrate metabolism in type II diabetes |
| Q42444615 | Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus |
| Q41015653 | Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. |
| Q54398069 | Effect of chronically elevated androgen or estrogen on the glucose tolerance test and insulin response in female rhesus monkeys. |
| Q42468760 | Effect of nifedipine on glucose potentiation of the acute insulin response to arginine in non-insulin-dependent diabetics |
| Q64905199 | Effects of Allium hookeri root water extracts on inhibition of adipogenesis and GLUT-4 expression in 3T3-L1 adipocytes. |
| Q52266950 | Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. |
| Q73384096 | Evidence of enhancement of malate-aspartate shuttle activity in beta cells of streptozotocin-induced non-insulin-dependent diabetic rats |
| Q38163729 | Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes |
| Q44956803 | Gliclazide at a lower concentration than therapeutic dose increases the sensitivity of insulin secretion to glucose in perfused rat pancreas |
| Q43623564 | Glucagon-like peptide-1 7-36: a physiological incretin in man. |
| Q35954178 | High 24-hour urinary C-peptide excretion in non-insulin dependent diabetes mellitus |
| Q90294355 | Higher C-Peptide Level During Glucose Clamp Is Associated With Muscle Insulin Resistance in Nonobese Japanese Men |
| Q42478438 | Hyperresponse in calcium-induced insulin release from electrically permeabilized pancreatic islets of diabetics GK rats and its defective augmentation by glucose |
| Q51635736 | Impaired insulin secretion in human diabetes mellitus. Effect of pharmacological activation of gamma-aminobutyric acid system. |
| Q44766906 | In vivo insulin secretion and action in hyperglycemic rat. |
| Q40880365 | Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamide |
| Q51629557 | Insulin deficiency and insulin resistance in type 2 (non-insulin-dependent) diabetes: quantitative contributions of pancreatic and peripheral responses to glucose homeostasis. |
| Q68934603 | Insulin deficiency in non-insulin-dependent diabetics |
| Q68130178 | Insulin release by glucose anomers in a rat model of non-insulin-dependent diabetes |
| Q34808246 | Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease |
| Q41452193 | Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics |
| Q39532297 | Insulin treatment of non-insulin-dependent diabetes mellitus |
| Q43190955 | JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats. |
| Q73258236 | Lundh meal: a single non-invasive challenge test for evaluation of exocrine and endocrine pancreatic function in cystic fibrosis patients |
| Q38739315 | Maturity-onset diabetes of the young (MODY). |
| Q51636959 | Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. |
| Q41263269 | Metabolic effects of biosynthetic human proinsulin in type 2 diabetes mellitus |
| Q44016349 | Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients |
| Q51629651 | No effect of gliclazide on gastric inhibitory polypeptide (GIP) in type II diabetes. |
| Q30597265 | Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future |
| Q51623748 | Polymorphism at the 5' end flanking region of the insulin gene is associated with reduced insulin secretion in healthy individuals. |
| Q35954506 | Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice. |
| Q36960161 | Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability |
| Q43612197 | Redefining treatment choice in type 2 diabetes: highlights of the Experts' Forum Meeting, Monte Carlo, 4-7 May 2000. |
| Q72572835 | Reduced sensitivity of dihydroxyacetone on ATP-sensitive K+ channels of pancreatic beta cells in GK rats |
| Q39298394 | Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium |
| Q35920736 | Synapsins I and II are not required for β-cell insulin secretion: granules must pool their own weight |
| Q44645531 | Targeting Postprandial Hyperglycemia: A Comparative Study of Insulinotropic Agents in Type 2 Diabetes |
| Q33752748 | The diagnosis and classification of diabetes mellitus in nonpregnant adults |
| Q68194858 | The effect of short-term basal insulin supplementation with human ultralente insulin on diurnal glycemic control in NIDDM patients |
| Q35954163 | The effects of diet and exercise in the treatment of non-insulin dependent diabetes mellitus |
| Q33891620 | The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus |
| Q43262866 | The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition |
| Q39764276 | The kinetics of insulin in man. I. General aspects |
| Q35120343 | The major diabetes prevention trials |
| Q46703824 | The opposing effects of the flavonoids isoquercitrin and sissotrin, isolated from Pterospartum tridentatum, on oral glucose tolerance in rats |
| Q33562758 | The protective effect of berberine on β-cell lipoapoptosis |
| Q35085591 | The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes |
| Q38692426 | The role of chemicals in the etiology of diabetes mellitus |
| Q34195301 | The role of immunotherapy in type I diabetes mellitus. |
| Q59485140 | The serum insulin and plasma glucose responses to milk and fruit products in Type 2 (non-insulin-dependent) diabetic patients |
| Q46142884 | World Congress on the Insulin Resistance Syndrome, 2009: Insulin resistance mechanisms, the brain, and insulin resistance in youth and in the polycystic ovary syndrome |
| Q51626339 | [Relation between body fat distribution, insulin levels and glucose tolerance in obese females]. |
Search more.